NCT07443202Phase 2Enrolling by invitation

Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Study sponsor: Tarsus Pharmaceuticals, Inc. · TARS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2026-12-31Estimated
Enrollment · participants155Estimated
Source updated2026-03-02Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.